-
Hair Thinning? Britannia Life Sciences Launches CBD Trial For Hair Loss Treatment
Monday, February 14, 2022 - 6:08pm | 258Britannia Life Sciences Inc. (CSE: BLAB), a global product development platform for cosmetic and wellness products, is launching a consumer trial to test the efficacy of CBD oil as an active ingredient in the treatment of hair loss. This hair growth initiative is aligned with Britannia's...
-
Concert Pharma Sees US Application Submission For Patchy Hair Loss Candidate In 2023
Thursday, July 1, 2021 - 1:44pm | 229Concert Pharmaceuticals Inc (NASDAQ: CNCE) has announced updated data from its ongoing open-label, long-term extension study of CTP-543 in patients with moderate to severe alopecia areata. Alopecia areata is an autoimmune disorder that results in patchy or complete hair loss. ...